Funder
National Key Research and Development Program of China
Chengdu Science and Technology Program
Basic and Applied Basic Research Foundation of Guangdong Province
Sichuan University
National Natural Science Foundation of China
Subject
Organic Chemistry,Drug Discovery,Pharmacology,General Medicine
Reference521 articles.
1. Properties of FDA-approved small molecule protein kinase inhibitors: a 2021 update;Roskoski;Pharmacol. Res.,2021
2. Kinase inhibitors: the road ahead;Ferguson;Nat. Rev. Drug Discov.,2018
3. Enhancing the therapeutic efficacy of nanoparticles for cancer treatment using versatile targeted strategies;Tian;J. Hematol. Oncol.,2023
4. Emerging role of tumor cell plasticity in modifying therapeutic response,;Qin;Signal Transduct Target Ther,2020
5. Approved and experimental small-molecule oncology kinase inhibitor drugs: a mid-2016 overview;Fischer;Med. Res. Rev.,2017
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献